| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |